The 61st STS Annual Meeting – Conference Preview on Thoracic Oncologic Surgery

Published on

The 61st Society of Thoracic Surgeons (STS) Annual Meeting will be held from January 24 to 26, 2025 at the Los Angeles Convention Center in California. This prestigious event is the leading annual gathering in the field of cardiothoracic surgery, showcasing cutting-edge research, innovative techniques, and advancements in technology. Attendees will have the opportunity to engage in discussions, network with colleagues, and establish lasting professional relationships.

To secure your attendance at this esteemed event, we highly recommend registering promptly by clicking this link. By doing so, you will have the chance to secure accommodations, access travel information, plan your itinerary, and guarantee your participation in educational and networking activities before they reach full capacity.

Below, you will find a list of sessions on thoracic oncologic surgery that we are eagerly looking forward to at STS 2025. The sessions are organized in chronological order for your convenience.

Esophageal Cancer: Current Advances and Controversies

  • Date/Time: Friday, January 24, 2025 9:45 am – 11:45 am
  • Location: 408A
  • Presentation topics include:
    • Esophagectomy vs. Gastrectomy for Gastroesophageal Junction Tumors
    • Open Esophagectomy: Tips and Techniques
    • RAMIE Tips and Tricks: Is RAMIE the Preferred Approach? Update on Trials

Thoracic Oncologic Surgery in 2025: Innovation and Re-Appraisal of Dogma

  • Date/Time: Friday, January 24, 2025 9:45 am – 11:45 am
  • Location: 408B
  • Presentation topics include:
    • Optimal Intrathoracic Pressure Setting Level of a Digital Thoracic Drainage System for Managing Air Leakage After Anatomical Pulmonary Resection: The Thop-Air Multicenter Randomized Controlled Trial
    • Does This Lymph Node Look Bulky to You? What Should We Do About It? A Survey of Thoracic Surgeons.
    • Sublobar Resection Is Not Associated with Increased Risk of Recurrence in Stage I Non-Small Cell Lung Cancer with Lymphovascular Invasion

Extent of Resection and Quality Metrics in Lung Cancer Care: From the Patient-Level to the Programmatic-Level

  • Date/Time: Friday, January 24, 2025 1:00 pm – 3:10 pm
  • Location: 408A
  • Presentation topics include:
    • Wedge Resection: Current State and Importance of Quality
    • Sublobar Resection Is Associated with Decreased Overall Survival in Stage I Non-Small Cell Lung Cancer with Tumor Spread Through Air Spaces
    • Impact of Frozen Section Pathology Examination of Surgical Margins in Sublobar Pulmonary Resections for Clinical Stage IA NSCLC

Multimodal Treatment of Pleural Mesothelioma after the MARS-2 trial: Will We Change Our Ways?

  • Date/Time: Saturday, January 25, 2025 10:15 am – 11:45 am
  • Location: 408A
  • Presentation topics include:
    • The New IASLC TNM Pleural Mesothelioma Staging and Its Effect on Treatment Options
    • Novel Perioperative Analgesia Modalities During Pleurectomy and Decortication for Pleural Mesothelioma
    • Novel Perioperative Analgesia Modalities During Pleurectomy and Decortication for Pleural Mesothelioma

Surgery for Stage IV Lung Cancer: Getting Surgeons in the Game for Advanced Disease

  • Date/Time: Saturday, January 25, 2025 10:15 am – 11:45 am
  • Location: 408B
  • Presentation topics include:
    • Why Are We Operating in Stage IV Disease?
    • What Operation Should You Do?
    • Outcomes of Lung Resection for M1 Non-Small Cell Lung Cancer in Modern Clinical Practice

Thoracic Oncology for the Cardiothoracic Surgeon: What You Really Need to Know in 2025

  • Date/Time: Sunday, January 26, 2025 10:15 am – 11:15 am
  • Location: 408A
  • Presentation topics include:
    • When to Refer for Neoadjuvant
    • When to Do a Sublobar Resection
    • What’s Adequate Staging/Profiling?

Lung Cancer Challenges in Resectable Disease: It’s a Whole New World

  • Date/Time: Sunday, January 26, 2025 11:30 am – 1:00 pm
  • Location: 408A
  • Presentation topics include:
    • Not All T4 Patients Should Be Considered Equal: NSCLC Heterogeneity and Surgical Outcome
    • Delayed Surgery Decreases Overall Survival in Early-Stage Non-Small Cell Lung Cancer: A Propensity Matched Cohort Analysis
    • Utilization and Survival Outcomes of Surgical Resection for Clinical Stage IIIB Non-Small Cell Lung Cancer


The 61st STS Annual Meeting promises to be a stimulating and informative event, featuring in-depth discussions on the latest advancements in thoracic oncologic surgery. We highly recommend exploring all the sessions that STS 2025 has to offer by clicking here. Attendees can expect to gain valuable insights and knowledge, making this event both enlightening and captivating. We are eager to witness the impact this event will have on the future of thoracic oncologic surgery and anticipate the valuable connections that will be forged.

Sign up for alerts and stay informed on the latest published guidelines and stay tuned for our recap post the conference.


Copyright © 2024 Guideline Central, All Rights Reserved.